Publicaciones
-
Theron A, Alonso-Saladrigues A, Dapena JL, López-Duarte M, Diaz de Heredia C, Verdú-Amorós J, Sarrate E, Esperanza-Cebollada E, Cuatrecasas E, Andreu S, Conde N, Sanchez-Sierra N, Isola I, Camós-Guijosa M, Torrebadell-Burriel M, Rives-Solà S and Català-Temprano A.
Secondary haematological dysplasia after CAR-T-cell therapy for acute lymphoblastic leukaemia in children
BRITISH JOURNAL OF HAEMATOLOGY . : .
-
Berrueco R, Nuria Caballero Mencía, López-Tierling M, Benedicto C, Cristina González-Anleo López, Rodríguez-Nieva N, David Nadal Miquel, Vinyets J and Jabalera M.
Mapping the Patient Experience in a Pediatric Hemophilia Unit: Our Patient Journey.
Journal of Clinical Medicine . 13(20): .
-
Bohlen J, Bagaric I, Vatovec T, Ogishi M, Ahmed SF, Cederholm A, Buetow L, Sobrino S, Le Floc'h C, Arango-Franco CA, Seabra L, Michelet M, Barzaghi F, Leardini D, Saettini F, Vendemini F, Baccelli F, Català-Temprano A, Gambineri E, Veltroni M, Aguilar de la Red Y, Rice GI, Consonni F, Berteloot L, Largeaud L, Conti F, Roullion C, Masson C, Bessot B, Seeleuthner Y, Le Voyer T, Rinchai D, Rosain J, Neehus AL, Erazo-Borrás L, Li H, Janda Z, Cho EJ, Muratore E, Soudée C, Lainé C, Delabesse E, Goulvestre C, Ma CS, Puel A, Tangye SG, André I, Bole-Feysot C, Abel L, Erlacher M, Zhang SY, Béziat V, Lagresle-Peyrou C, Six E, Pasquet M, Alsina L, Aiuti A, Zhang P, Crow YJ, Landegren N, Masetti R, Huang DT, Casanova JL and Bustamante J.
Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERIC-mediated monocyte activation
JOURNAL OF CLINICAL INVESTIGATION . 134(20): .
-
Mato S, Castrejón-de-Anta N, Colmenero A, Carità L, Salmerón-Villalobos J, Ramis-Zaldivar JE, Nadeu F, Garcia N, Wang L, Verdú-Amorós J, Andrés M, Conde N, Celis-Passini V, Ortega MJ, Galera A, Astigarraga I, Perez-Alonso V, Quiroga E, Jiang A, Scott DW, Campo E, Balagué O and Salaverria I.
MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma
BLOOD CANCER JOURNAL . 14(1): 171-171.
-
González de Aledo-Castillo JM, Argudo-Ramírez A, Beneitez-Pastor D, Collado-Gimbert A, Almazán Castro F, Roig-Bosch S, Andrés-Masó A, Ruiz-Llobet A, Pedrals-Portabella G, Medina-Santamaria D, Nadal-Rey G, Espigares-Salvia M, Coll-Sibina MT, Algar-Serrano M, Torrent-Español M, Leoz-Allegretti P, Rodríguez-Pebé A, García-Bernal M, Solà-Segura E, García-Gallego A, Prats-Viedma B, López-Galera RM, Paredes-Fuentes AJ, Pajares García S, Delgado-López G, Blanco-Álvarez A, Tazón-Vega B, Díaz de Heredia C, Mañú-Pereira MDM, Marín-Soria JL, García-Villoria J, Velasco-Puyó P and On Behalf Of The Sickle Cell Disease Newborn Screening Group Of Catalonia.
Newborn Screening for Sickle Cell Disease in Catalonia between 2015 and 2022-Epidemiology and Impact on Clinical Events.
International Journal of Neonatal Screening . 10(4): .
-
Ruiz-Llobet A, Gassiot S, Sarrate E, Zubicaray J, Rives-Solà S, Suleman W and Berrueco R.
Thrombin Generation Profile Using ST-Genesia after PEG-asparaginase in Pediatric Patients with Acute Lymphoblastic Leukemia.
THROMBOSIS AND HAEMOSTASIS . 124(10): 973-985.
-
Pennesi E, Brivio E, Ammerlaan ACJ, Jiang Y, Van der Velden VHJ, Beverloo HB, Sleight B, Locatelli F, Brethon B, Rossig C, Engstler G, Nilsson A, Bruno B, Petit A, Bielorai B, Rizzari C, Rialland F, Rubio-San-Simón A, Sirvent FJB, Diaz-de-Heredia C, Rives-Solà S and Zwaan CM.
Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22+ acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial
HAEMATOLOGICA . 109(10): 3157-3166. Nº de citas: 4
-
Sánchez-Espino LF, Ivars M, Prat-Torres CS, Lavarino C, Gene-Olaciregui N, Rovira-Zurriaga C, Celis-Passini V, Miguel Bejarano Serrano and Baselga E.
Single dominant lesion in capillary malformation-arteriovenous malformation (CM-AVM) RASA1 syndrome.
PEDIATRIC DERMATOLOGY . 41(5): 861-865.
-
Mingot-Castellano ME, Reguera-Ortega JL, Zafra Torres D, Hernani R, Lopez-Godino O, Guerreiro M, Herrero B, López-Corral L, Luna A, Gonzalez-Pinedo L, Chinea-Rodriguez A, Africa-Martín A, Bailen R, Martinez-Cibrian N, Balsalobre P, Filaferro S, Alonso-Saladrigues A, Barba P, Perez-Martinez A, Calbacho M, Perez-Simón JA, Sánchez-Pina JM and On Behalf Of The Spanish Group Of Hematopoietic Transplant And Cell Therapy Get.
Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients.
Journal of Clinical Medicine . 13(17): .
-
Velasco Puyó P, Tagarro A, Garcia-Obregon S, Villate Bejarano O, Moraleda C, Huerta Aragonés J, Bardón Cancho EJ, Faura A, Galán-Gómez V, Escobar Fernández L, Lendinez-Molinos F, Herrero Velasco B, Ureña Horno L, Domínguez-Pinilla N, Pascual Gazquez JF, Nova Lozano C, Osuna-Marco M, Marín-Cruz I, Gomez Pastrana I, Garcia de Andoin Barandiaran N, Gallego Mingo N, Portugal Rodríguez R, Cañete A, Pareja León M, Castrillo Bustamante S, Tallón García M, Gónzalez-Prieto A, Solé-Rodríguez M, González Cruz M, Soriano-Arandes A, Mota M, Pérez-Hoyos S, Moreno L and Astigarraga I.
Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities.
PEDIATRIC BLOOD & CANCER . 71(8): .